Cas:109346-95-4 2-(3,5-dichlorophenyl)acetaldehyde manufacturer & supplier

We serve Chemical Name:2-(3,5-dichlorophenyl)acetaldehyde CAS:109346-95-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3,5-dichlorophenyl)acetaldehyde

Chemical Name:2-(3,5-dichlorophenyl)acetaldehyde
CAS.NO:109346-95-4
Synonyms:Benzeneacetaldehyde,3,5-dichloro
Molecular Formula:C8H6Cl2O
Molecular Weight:189.03900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:17.07000
Exact Mass:187.98000
LogP:2.73480

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzeneacetaldehyde,3,5-dichloro chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzeneacetaldehyde,3,5-dichloro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzeneacetaldehyde,3,5-dichloro Use and application,Benzeneacetaldehyde,3,5-dichloro technical grade,usp/ep/jp grade.


Related News: In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape. 2-(3,5-dichlorophenyl)acetaldehyde manufacturer As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 2-(3,5-dichlorophenyl)acetaldehyde supplier The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus. 2-(3,5-dichlorophenyl)acetaldehyde vendor AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. 2-(3,5-dichlorophenyl)acetaldehyde factory The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus.